Target intelligence / Profile preview

Bitis arietans disintegrins and C-type lectin venom proteins

Molecular classification
Snake venom protein, Disintegrin, C-type lectin-like protein, Snaclec
01

Overview

Bitis arietans disintegrins and C-type lectin-like proteins (Snaclecs) are key non-enzymatic components of the Puff Adder venom that potently disrupt the host's hemostatic system (PLOS Neglected Tropical Diseases, 2023). Disintegrins, such as bitistatin (also known as arietin), are small, cysteine-rich peptides that typically utilize an RGD (Arg-Gly-Asp) motif to competitively inhibit the binding of fibrinogen to the platelet integrin alpha-IIb/beta-3, thereby preventing platelet aggregation (UniProt P17497). C-type lectin-like proteins, including the bitiscetin family (bitiscetin-1, -2, and -3), are heterodimeric proteins that interact with von Willebrand factor (VWF) or the platelet glycoprotein Ib (GPIb) receptor (MDPI Toxins, 2022). These interactions lead to either platelet agglutination or the inhibition of VWF-collagen interactions, further compromising blood clotting (Toxicon, 2005). During envenomation, the synergistic action of these proteins results in severe systemic hemorrhage, thrombocytopenia, and coagulopathy, which are the primary clinical manifestations of a Puff Adder bite (NIH, 2023). Consequently, these proteins are the primary targets for neutralization by polyvalent antivenoms in clinical settings (PLOS Neglected Tropical Diseases, 2023). Furthermore, their high affinity and specificity for cardiovascular receptors have made them significant leads in the design of therapeutic antithrombotic agents (ResearchGate, 2022).

Other names
Puff adder disintegrinsPuff adder C-type lectinsSnaclecsBitistatinBitiscetinArietinBitan-alphaBitiscetin-1Bitiscetin-2Bitiscetin-3Ba25
02

Mechanism of action

Neutralization of venom toxins by polyclonal antibodies to prevent binding to physiological targets such as integrins and von Willebrand factor (NIH, 2023).

03

Biological functions

Platelet aggregation inhibitionPlatelet agglutination inductionCell adhesion inhibitionvon Willebrand factor bindingIntegrin binding
04

Disease associations

Snakebite envenomationCoagulopathyThrombocytopeniaHemorrhage
05

Safety considerations

HemorrhageThrombocytopeniaAnaphylaxisSerum sickness
06

Interacting drugs

SAIMR Polyvalent Antivenom

2 more in the full profile.

07

Biomarkers

Platelet countFibrinogen levelProthrombin timeActivated partial thromboplastin time

Beyond the preview

Go deeper on Bitis arietans disintegrins and C-type lectin venom proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bitis arietans disintegrins and C-type lectin venom proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call